These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23026443)

  • 1. Naturally mutated envelope protein domain I of Chinese B dengue virus attenuated human dendritic cell maturation.
    Li J; Zhang X; Zuo L; Shang Z; Sun R
    Int Immunopharmacol; 2012 Dec; 14(4):683-9. PubMed ID: 23026443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.
    Tan LC; Chua AJ; Goh LS; Pua SM; Cheong YK; Ng ML
    Protein Expr Purif; 2010 Nov; 74(1):129-37. PubMed ID: 20600950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic Fever patient.
    Kinoshita H; Mathenge EG; Hung NT; Huong VT; Kumatori A; Yu F; Parquet MC; Inoue S; Matias RR; Natividad FF; Morita K; Hasebe F
    Jpn J Infect Dis; 2009 Sep; 62(5):343-50. PubMed ID: 19762982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
    De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
    Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
    Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
    Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
    Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
    Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
    Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice.
    Block OK; Rodrigo WW; Quinn M; Jin X; Rose RC; Schlesinger JJ
    Vaccine; 2010 Nov; 28(51):8085-94. PubMed ID: 20959154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
    Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
    Alen MM; Dallmeier K; Balzarini J; Neyts J; Schols D
    Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells.
    Chase AJ; Medina FA; Muñoz-Jordán JL
    J Infect Dis; 2011 Jun; 203(12):1763-74. PubMed ID: 21606535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
    Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
    J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
    Amorim JH; Pereira Bizerra RS; dos Santos Alves RP; Sbrogio-Almeida ME; Levi JE; Capurro ML; de Souza Ferreira LC
    PLoS One; 2012; 7(9):e44984. PubMed ID: 23028722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J; Cheah CY; AbuBakar S
    Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
    Jaiswal S; Khanna N; Swaminathan S
    Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an in vitro model.
    Nantachit N; Sunintaboon P; Ubol S
    Microbiol Immunol; 2017 Aug; 61(8):305-317. PubMed ID: 28603864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
    Kuruvilla JG; Troyer RM; Devi S; Akkina R
    Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus.
    Suzarte E; Marcos E; Gil L; Valdés I; Lazo L; Ramos Y; Pérez Y; Falcón V; Romero Y; Guzmán MG; González S; Kourí J; Guillén G; Hermida L
    Arch Virol; 2014 Jul; 159(7):1629-40. PubMed ID: 24420159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.